gilead sciences inc
(GILD:Consolidated Issue Listed on NASDAQ Global Select )
Joel R. Huff Ph.D.
Chairperson of Scientific Advisory Board,Gilead Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 37 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Joel R. Huff, Ph.D. served as Vice President of Medicinal Chemistry at Merck Research Laboratories until 2004, following 30 years of service. Dr. Huff serves as a Member of the Scientific Advisory Board of Epizyme, Inc. At Merck he led efforts to develop therapeutic agents for HIV, resulting in the discovery of indianvir (Crixivan®), and efavirenz (Stocrin®, Sustiva®). Dr. Huff serves as the Chairperson of Scientific Advisory Board at Gilead Sciences Inc. Dr. Huff ...
333 Lakeside DrivePhone: 650-574-3000
Foster City, California 94404
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
The University of Texas, Austin
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Olivier Brandicourt||Chief Executive Officer and Director|
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.6M||Compensation as of Fiscal Year 2014.|